Evaluation of sexual functioning depressed outpatients: A double-blind comparison of sustained-release bupropion and sertraline treatment

Journal of Clinical Psychopharmacology

Volumn 20, Issue 2, 2000, Pages 122-128

  Segraves, R Taylor ^a   Kavoussi, Richard ^b   Hughes, Arlene R ^c   Batey, Sharyn R ^c   Johnston, J Andrew ^c   Donahue, Rafe ^c   Ascher, John A ^c  

^a METROHEALTH MEDICAL CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EJACULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGASM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SUSTAINED RELEASE PREPARATION;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DELAYED-ACTION PREPARATIONS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; SERTRALINE; SEXUAL BEHAVIOR;

EID: 0034087358     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200004000-00002     Document Type: Article

References (26)

1. Segraves RT. Overview of sexual dysfunction complicating the treatment of depression. J Clin Psychiatry Monogr 1992;10:4-10.
2. Balon R, Yeragani VK, Pohl R, Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993;54:209-12.
3. Thase ME, Reynolds CF, Jennings JR, Frank E, Howell JR, Houck PR, Berman S, Kupfer DJ. Nocturnal penile tumescence is diminished in depressed men. Biol Psychiatry 1988;24:33-46.
4. Tamburello A, Seppecher MF. The effects of depression on sexual behavior: preliminary results of research. In: Gemme R, Wheeler CC, eds. Progress in sexology. New York: Guilford Press, 1988: 232-46.
5. Casper RC, Redmond E, Katz MM, Schaeffer CB, Davis JM, Koslow SH. Somatic symptoms in primary affective disorder. Arch Gen Psychiatry 1985;42:1098-104.
6. Patterson WM. Fluoxetine-induced sexual dysfunction [letter]. J Clin Psychiatry 1993;54:2.
7. Singh AN, Scurlock H, Catalan J. Paroxetine induced erectile dysfunction successfully treated with yohimbine in patients suffering from HIV infection. J Serotonin Res 1995;4:283-5.
8. Meston CM, Gorzalka BB. Psychoactive drugs and human sexual behavior: the role of serotonergic activity. J Psychoactive Drugs 1992;24:1-40.
9. Reimherr FW, Chouinard G, Cohn CK, Cole JO, Itil TM, LaPierre YD, Masco HL, Mendels J. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 1990;51:18-27.
10. Cohn CK, Shrivastava R, Mendels J, Cohn JB, Fabre LR, Claghorn JL, Dessain EC, Itil TM, Lautin A. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990;51:28-33.
11. Doogan DP, Caillard V. Sertraline: a new antidepressant. J Clin Psychiatry 1988;49[suppl 8]:46-51.
12. Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996;57[suppl 2]:53-62.
13. Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG. Double-blind comparison of bupropion and fluoxetine in depressed outpatients. J Clin Psychiatry 1991;52:329-35.
14. Chouinard G. Bupropion and amitriptyline in the treatment of depressed patients. J Clin Psychiatry 1983;44:121-9.
15. Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatry 1997;58: 532-7.
16. Ascher JA, Cole JO, Colin J, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E, Sulser F. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395-401.
17. Ferris RM, Cooper BR. Mechanism of antidepressant activity of bupropion. J Clin Psychiatry Monogr 1993;11:2-14.
18. Gardner EA, Johnston JA. Bupropion: an antidepressant without sexual pathophysiological action. J Clin Psychopharmacol 1985; 5:24-9.
19. Modell JG, Katholi CR, Modell, JD, DePalma RL. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther 1997;61:476-87.
20. Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, Lineberry CG. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 1993;54:459-65.
21. Gardner EA. Long-term preventive care in depression: the use of bupropion in patients intolerant of other antidepressants. J Clin Psychiatry 1983;44:157-62.
22. Labbate LA, Pollack MH. Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry 1994;6:13-5.
23. Bodkin JA, Lasser RA, Wines JD, Gardner DM, Baldessarini RJ. Combining serotonin reuptake inhibitors in partial responders to antidepressant monotherapy. J Clin Psychiatry 1997;58:137-45.
24. Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 1998;59:112-5.
25. Graham CA, Ramos R, Bancroft J, Maglaya C, Farley TMM. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception 1995; 52:363-9.
26. Sertraline (Zoloft) product information. New York: Pfizer Inc., 1996.